EpiTherapeutics

EpiTherapeutics is a biopharmaceutical company developing novel innovative cancer drugs based on world leading research in the field of epigenetics

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

EpiTherapeutics is a biopharmaceutical company developing novel innovative cancer drugs based on world leading research in the field of epigenetics. The company focuses on enzymes involved in the regulation of transcription in cancer, targeting histone demethylases and methyltransferases.

02Backed By1 investor

SCSeed Capital→

03Similar Companies

Is this your company? Claim your profile